Clinical Trials in Chicago

Showing 5161-5180 of 15,574 trials

Depression Return to Work Intervention

NCT06026280

This study is a randomized controlled trial to test the effectiveness of a mobile app-based program aimed to help individuals with unemployment-related emotional distress return to work.

Job StressDistress, Emotional

Inspiration at Work141 participantsStarted Aug 2023

Chicago, Illinois, United States

WITHDRAWNPhase 1/22.2 miles

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

NCT03973333

IMC-C103C is an immune mobilizing monoclonal T cell receptor against cancer (ImmTAC ®) designed for the treatment of cancers positive for the tumor-associated antigen MAGE-A4. This is a first-in-human trial designed to evaluate the safety and efficacy of IMC-C103C in adult patients who have the appropriate HLA-A2 tissue marker and whose cancer is positive for MAGE-A4.

Select Advanced Solid Tumors

Immunocore LtdStarted May 2019

Los Angeles, California, United States • Sacramento, California, United States • Aurora, Colorado, United States +16 more locations

Depression Return to Work Intervention

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Find Trials by Condition in Chicago

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Hypotension Prediction Index Study (HPI Study)

SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission

Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure

A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101

Assessment of Macrophage Activation syndromE in STill's Disease

Milademetan in Advanced/Metastatic Solid Tumors

Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

Comparative Effectiveness of Direct Admission & Admission Through Emergency Departments for Children

Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)